Zynerba Pharmaceuticals - 3 Year Stock Split History | ZYNE
Stock split history for Zynerba Pharmaceuticals since 2015. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
|Zynerba Pharmaceuticals Annual Stock Splits
|Zynerba Pharmaceuticals Quarterly Stock Splits
||Medical - Generic Drugs
Zynerba Pharmaceuticals, Inc. is a specialty pharmaceutical company which focuses on developing and commercializing proprietary synthetic cannabinoid therapeutics formulated for transdermal delivery. Its product candidates which are in clinical trial stage include ZYN002 and ZYN001 synthetic transdermal cannabinoid therapeutics for indications including refractory epilepsy, Fragile X syndrome, osteoarthritis, fibromyalgia and peripheral neuropathic pain. Zynerba Pharmaceuticals, Inc. is headquartered in Devon, Pennsylvania.